TheEdgeResearch
Home / Stocks / BIS

ProShares - UltraShort Nasdaq Biotechnology (BIS)

NASDAQ Financial Services Asset Management - Leveraged
$13.95 ▼ -4.32%
Market Cap
$2.3M
Sector
Financial Services
Industry
Asset Management - Leveraged
Beta
-1.18
52-Wk Range
13.81-35.58
CEO
Country
US
Currency
USD

The ProShares UltraShort Nasdaq Biotechnology fund is engineered to achieve daily returns that are precisely two times the inverse (-2x) of the Nasdaq Biotechnology Index's daily performance. This objective is measured before accounting for any associated fees and operational expenses.

Open full interactive analysis & DCF →